Sergio Infante

Sergio Infante, MD, is an Associate Professor in the Department of Medicine at the School of Medicine and an Assistant Professor in the Department of Pharmacy Practice at the School of Pharmacy, both at Loma Linda University. His dual appointment reflects his interdisciplinary expertise in clinical nephrology and pharmacy practice, particularly in managing patients with kidney disease and optimizing medication regimens in renal impairment.

• Associate Professor, Department of Medicine, School of Medicine, Loma Linda University
• Assistant Professor, Department of Pharmacy Practice, School of Pharmacy, Loma Linda University

Dr. Infante's research focuses on nephrology, transplantation, and pharmaceutical care in chronic and critical illness. His work addresses key clinical challenges such as drug dosing in continuous renal replacement therapy, bone health in dialysis patients, outcomes in kidney transplant recipients, and mental health in end-stage renal disease. He also investigates interdisciplinary models of care to improve patient adherence and outcomes in dialysis.

His recent publications (2017–2024) demonstrate consistent scholarly output across nephrology, pharmacy, and internal medicine journals. These studies include case reports, clinical research, and interdisciplinary reviews, with a strong emphasis on practical applications in patient management. Themes in his research include mineral and bone disorders in CKD, ultrafiltration strategies, post-transplant complications, and the intersection of mental health with chronic kidney disease.

Dr. Infante has been actively involved in multiple research projects, including investigator roles in industry-sponsored and internally funded studies. Notably, he served as Principal Investigator (PD/PI) on a grant from LLU-GRASP (2021–2025) examining lithium use in depression and suicidal ideation among ESRD patients, indicating leadership in psychonephrology research.

• Evaluation of polymyxin B hemoperfusion in septic shock (EUPHRATES) – Investigator (Spectral Diagnostics Inc., 2014–2015)
• Assessment of kidney disease in COVID-19 patients – Investigator (LLU Dept. of Medicine, 2021)
• Literacy and numeracy in dialysis medication labeling – Investigator (LLU Dept. of Pharmacy, 2019)
• Clinical outcomes of induction therapies in transplant patients – Investigator (LLU Transplantation Institute, 2007–2015)
• Role of lithium in depression in ESRD – PD/PI (LLU-GRASP, 2021–2025)

While no formal lab or team is explicitly mentioned, his collaborative publications and project leadership suggest active participation in multidisciplinary research teams involving nephrology, pharmacy, psychiatry, and transplantation. His future work appears to focus on mental health in renal populations, patient education, and precision dosing in critical care nephrology.